Alphamab Oncology (stock code: 9966.HK) today announced that the first patient has been dosed in a phase III clinical study (JSKN016-301) evaluating JSKN016, a novel TROP2/HER3 bispecific ...
MVID has a lethal natural history requiring life-sustaining parenteral support (PS), which includes total parenteral ...
Led by researchers at NDORMS as part of the Data Analysis and Real World Interrogation Network (DARWIN EU) initiative, a new ...
TenoMiR to Progress to Phase 3 Study for Lateral Epicondylitis, Making it One of the Most Advanced microRNA Clinical Programs GLASGOW, Scotland, March 19, 2026 (GLOBE NEWSWIRE) -- Causeway ...
Artelo Biosciences (NASDAQ:ARTL) is expanding its development pipeline into ophthalmology with a new clinical study evaluating its drug candidate ART27.13 for the treatment of glaucoma. The San ...
GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of ...
Residual gastric volume precluded endoscopic examination ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Two international studies, a clinical trial led by the University of Oxford and University of Utrecht, and a qualitative ...
LAKE ZURICH, IL, UNITED STATES, March 17, 2026 /EINPresswire.com/ -- The Sikh community in the United States, estimated ...
Sarasota Memorial Hospital is part of a global research effort on an option to traditional cardiac resynchronization therapy.
ClinCapture announces AI-powered clinical trial build tech that automates study configuration, and advances intelligent ...